XORTX Therapeutics Inc.

NASDAQ: XRTX · Real-Time Price · USD
0.80
-0.02 (-2.68%)
At close: Aug 18, 2025, 3:59 PM
0.79
-1.25%
After-hours: Aug 18, 2025, 07:58 PM EDT

XORTX Therapeutics Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 141.96K 75.27K 17.88K
Gross Profit
n/a -141.96K -75.27K -17.88K
Operating Income
-3.59M -4.81M -10.69M -4.14M
Interest Income
n/a 257.65K 101.37K n/a
Pretax Income
-4.76M -2.15M -6.99M -1.3M
Net Income
-4.76M -2.15M -6.99M -1.3M
Selling & General & Admin
3.33M 2.39M 2.29M 1.58M
Research & Development
264.29K 2.41M 6.49M 669.11K
Other Expenses
n/a 0.00 n/a n/a
Operating Expenses
3.59M 4.81M 9.86M 2.86M
Interest Expense
n/a n/a n/a 4.39K
Selling & Marketing Expenses
1.74M 1.33M n/a n/a
Cost & Expenses
3.59M 4.81M 9.86M 2.86M
Income Tax Expense
n/a n/a 0.00 4.39K
Shares Outstanding (Basic)
2.88M 1.98M 1.48M 1.09M
Shares Outstanding (Diluted)
2.88M 1.98M 1.48M 1.09M
EPS (Basic)
-1.65 -1.08 -4.72 -1.19
EPS (Diluted)
-1.65 -1.08 -4.72 -1.19
EBITDA
-3.71M -4.87M -9.41M -1.63M
EBIT
-3.76M -6.57M -9.49M -2.92M
Depreciation & Amortization
55.71K 141.96K 75.27K 17.88K